Literature DB >> 18024426

Combinatorial control of exon recognition.

Klemens J Hertel1.   

Abstract

Pre-mRNA splicing is a fundamental process required for the expression of most metazoan genes. It is carried out by the spliceosome, which catalyzes the removal of noncoding intronic sequences to assemble exons into mature mRNAs prior to export and translation. Given the complexity of higher eukaryotic genes and the relatively low level of splice site conservation, the precision of the splicing machinery in recognizing and pairing splice sites is impressive. Introns ranging in size from <100 up to 100,000 bases are removed efficiently. At the same time, a large number of alternative splicing events are observed between different cell types, during development, or during other biological processes. This extensive alternative splicing implies a significant flexibility of the spliceosome to identify and process exons within a given pre-mRNA. To reach this flexibility, splice site selection in higher eukaryotes has evolved to depend on multiple parameters such as splice site strength, the presence or absence of splicing regulators, RNA secondary structures, the exon/intron architecture, and the process of pre-mRNA synthesis itself. The relative contributions of each of these parameters control how efficiently splice sites are recognized and flanking introns are removed.

Mesh:

Substances:

Year:  2007        PMID: 18024426     DOI: 10.1074/jbc.R700035200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  102 in total

1.  Functional implications of the emergence of alternative splicing in hnRNP A/B transcripts.

Authors:  Siew Ping Han; Karin S Kassahn; Adam Skarshewski; Mark A Ragan; Joseph A Rothnagel; Ross Smith
Journal:  RNA       Date:  2010-07-22       Impact factor: 4.942

2.  An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing.

Authors:  Natalia N Singh; Katrin Hollinger; Dhruva Bhattacharya; Ravindra N Singh
Journal:  RNA       Date:  2010-04-22       Impact factor: 4.942

3.  Retention of spliceosomal components along ligated exons ensures efficient removal of multiple introns.

Authors:  Tara L Crabb; Bianca J Lam; Klemens J Hertel
Journal:  RNA       Date:  2010-07-07       Impact factor: 4.942

4.  Characterization of splice variants of the genes encoding human mitochondrial HMG-CoA lyase and HMG-CoA synthase, the main enzymes of the ketogenesis pathway.

Authors:  Beatriz Puisac; Mónica Ramos; María Arnedo; Sebastián Menao; María Concepción Gil-Rodríguez; María Esperanza Teresa-Rodrigo; Angeles Pié; Juan Carlos de Karam; Jan-Jaap Wesselink; Ignacio Giménez; Feliciano J Ramos; Nuria Casals; Paulino Gómez-Puertas; Fausto G Hegardt; Juan Pié
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

5.  The Silent Sway of Splicing by Synonymous Substitutions.

Authors:  William F Mueller; Liza S Z Larsen; Angela Garibaldi; G Wesley Hatfield; Klemens J Hertel
Journal:  J Biol Chem       Date:  2015-09-30       Impact factor: 5.157

6.  Spliceosome assembly pathways for different types of alternative splicing converge during commitment to splice site pairing in the A complex.

Authors:  Matthew V Kotlajich; Tara L Crabb; Klemens J Hertel
Journal:  Mol Cell Biol       Date:  2008-12-08       Impact factor: 4.272

7.  Splice-site pairing is an intrinsically high fidelity process.

Authors:  Kristi L Fox-Walsh; Klemens J Hertel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-29       Impact factor: 11.205

Review 8.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

9.  Alternative splicing attenuates transgenic expression directed by the apolipoprotein E promoter-enhancer based expression vector pLIV11.

Authors:  Dongmei Cheng; Philip S MacArthur; Shunxing Rong; John S Parks; Gregory S Shelness
Journal:  J Lipid Res       Date:  2009-10-27       Impact factor: 5.922

Review 10.  CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease.

Authors:  Andrea N Ladd
Journal:  Mol Cell Neurosci       Date:  2012-12-14       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.